Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 7 Thoracic 1 Sarcoma 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 17 pembrolizumab 12 Doxorubicin 10 fludarabine 7 Irinotecan 7 Blood Specimen Collection 7 Temozolomide 6 Gemcitabine 6 Etoposide 6 Radiotherapy 5 Ifosfamide 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 tecogalan 4 cemiplimab 4 Vincristine 4 Trabectedin 4 Paclitaxel 4 Nivolumab 4 Filgrastim 4 Drug Therapy 4 Dexamethasone 4 Bevacizumab 4 pazopanib 3 olaparib 3 nilotinib 3 dostarlimab 3 aflibercept 3 Therapeutics 3 Taxes 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × ARQ 197 × Sarcoma × Clear all

NCT01468922 2022-07-01

Pazopanib and ARQ 197 for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

32 enrolled 21 charts

Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡